Cargando…

Circulating TGF-β Pathway in Osteogenesis Imperfecta Pediatric Patients Subjected to MSCs-Based Cell Therapy

Osteogenesis Imperfecta (OI) is a rare genetic disease characterized by bone fragility, with a wide range in the severity of clinical manifestations. The majority of cases are due to mutations in COL1A1 or COL1A2, which encode type I collagen. There is no cure for OI, and real concerns exist for cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Infante, Arantza, Cabodevilla, Leire, Gener, Blanca, Rodríguez, Clara I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865676/
https://www.ncbi.nlm.nih.gov/pubmed/35223854
http://dx.doi.org/10.3389/fcell.2022.830928